ロード中...
Immunologic functions as prognostic indicators in melanoma
Outcome in melanoma patients with advanced disease is poor and systemic treatment seems to benefit only a subset of patients. Predictive markers identifying these patients are currently not available. Early studies showed an association of immune‐related side effects such as vitiligo and autoimmune...
保存先:
| 出版年: | Mol Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528285/ https://ncbi.nlm.nih.gov/pubmed/21367679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2011.01.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|